58 related articles for article (PubMed ID: 28690852)
1. History and current status of polymyxin B-immobilized fiber column for treatment of severe sepsis and septic shock.
Shimizu T; Miyake T; Tani M
Ann Gastroenterol Surg; 2017 Jun; 1(2):105-113. PubMed ID: 29863114
[TBL] [Abstract][Full Text] [Related]
2. Clinical effects of polymyxin B-immobilized fiber column direct hemoperfusion for severe bacterial meningitis: A series of 10 cases.
Suzuki Y; Kawakami S; Yamada M; Sohmiya M; Shibuya K; Maeda N
Clin Case Rep; 2020 May; 8(5):823-832. PubMed ID: 32477526
[TBL] [Abstract][Full Text] [Related]
3. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis.
Fujii T; Ganeko R; Kataoka Y; Furukawa TA; Featherstone R; Doi K; Vincent JL; Pasero D; Robert R; Ronco C; Bagshaw SM
Intensive Care Med; 2018 Feb; 44(2):167-178. PubMed ID: 29204670
[TBL] [Abstract][Full Text] [Related]
4. Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: a systematic review and meta-analysis.
Wang G; He Y; Guo Q; Zhao Y; He J; Chen Y; Chen W; Zhou Y; Peng Z; Deng K; Guan J; Xie W; Chang P; Liu Z
Crit Care; 2023 Jul; 27(1):275. PubMed ID: 37424026
[TBL] [Abstract][Full Text] [Related]
5. Sepsis-Pathophysiology and Therapeutic Concepts.
Jarczak D; Kluge S; Nierhaus A
Front Med (Lausanne); 2021; 8():628302. PubMed ID: 34055825
[TBL] [Abstract][Full Text] [Related]
6. Early use of endotoxin absorption by oXiris in abdominal septic shock: A case report.
Wei T; Chen Z; Li P; Tang X; Marshall MR; Zhang L; Fu P
Medicine (Baltimore); 2020 Jul; 99(28):e19632. PubMed ID: 32664051
[TBL] [Abstract][Full Text] [Related]
7. Colorectal Perforation in Patients with Connective Tissue Disease.
Sugimoto K; Sakamoto K; Okazawa Y; Takahashi R; Mizukoshi K; Ro H; Kawai M; Kawano S; Munakata S; Ishiyama S; Kamiyama H; Takahashi M; Kojima Y; Tomiki Y; Tamura N
Emerg Med Int; 2019; 2019():5852438. PubMed ID: 31321099
[TBL] [Abstract][Full Text] [Related]
8. The wind changed direction and the big river still flows: from EUPHRATES to TIGRIS.
Iba T; Klein DJ
J Intensive Care; 2019; 7():31. PubMed ID: 31131109
[TBL] [Abstract][Full Text] [Related]
9. Cytokine removal in human septic shock: Where are we and where are we going?
Honore PM; Hoste E; Molnár Z; Jacobs R; Joannes-Boyau O; Malbrain MLNG; Forni LG
Ann Intensive Care; 2019 May; 9(1):56. PubMed ID: 31089920
[TBL] [Abstract][Full Text] [Related]
10. Immune therapy in sepsis: Are we ready to try again?
Davies R; O'Dea K; Gordon A
J Intensive Care Soc; 2018 Nov; 19(4):326-344. PubMed ID: 30515242
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls.
Ankawi G; Neri M; Zhang J; Breglia A; Ricci Z; Ronco C
Crit Care; 2018 Oct; 22(1):262. PubMed ID: 30360755
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an "endotoxin severity score" needed?
Honore PM; De Bels D; Preseau T; Redant S; Spapen HD
Crit Care; 2018 Aug; 22(1):205. PubMed ID: 30115067
[No Abstract] [Full Text] [Related]
13. Potentially Important Therapeutic Interactions between Antibiotics, and a Specially Engineered Emulsion Drug Vehicle Containing Krill-Oil-Based Phospholipids and Omega-3 Fatty Acids.
Driscoll DF
Antibiotics (Basel); 2018 Mar; 7(1):. PubMed ID: 29534425
[TBL] [Abstract][Full Text] [Related]
14. Polymyxin B hemoperfusion in septic shock: nothing overmuch (Meden Agan)!
Ilia S; Briassoulis P; Briassoulis G
J Thorac Dis; 2017 Sep; 9(9):2716-2719. PubMed ID: 29221222
[No Abstract] [Full Text] [Related]
15. Is polymyxin B-immobilized fiber column ineffective for septic shock? A discussion on the press release for EUPHRATES trial.
Iba T; Fowler L
J Intensive Care; 2017; 5():40. PubMed ID: 28690852
[TBL] [Abstract][Full Text] [Related]
16. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial.
Klein DJ; Foster D; Walker PM; Bagshaw SM; Mekonnen H; Antonelli M
Intensive Care Med; 2018 Dec; 44(12):2205-2212. PubMed ID: 30470853
[TBL] [Abstract][Full Text] [Related]
17. The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial.
Klein DJ; Foster D; Schorr CA; Kazempour K; Walker PM; Dellinger RP
Trials; 2014 Jun; 15():218. PubMed ID: 24916483
[TBL] [Abstract][Full Text] [Related]
18. Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock.
Mitaka C; Kusaoi M; Kawagoe I; Satoh D
Acute Crit Care; 2021 May; 36(2):85-91. PubMed ID: 33813808
[TBL] [Abstract][Full Text] [Related]
19. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
Mitaka C; Tomita M
Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
